Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Iomai awarded contract for adjuvant patch for use with pandemic influenza vaccine

Jan. 23, 2007

Rhucin awarded European orphan drug status

Jan. 18, 2007

European orphan drug designation for Prochymal

Jan. 18, 2007

Recent Actelion patent discloses new agents for transplant rejection and graft-versus-host disease

Jan. 17, 2007

MP-12 Rift Valley fever vaccine to be evaluated in phase II study

Jan. 15, 2007

Interim data from ragweed study of Tolamba

Jan. 15, 2007

Korea clears study of VM-106 genetic therapy for chronic granuloma

Jan. 11, 2007

Refrigerated formulation of FluMist receives FDA approval

Jan. 10, 2007

Sirolimus to be tested in clinical trial for ALPS / News in Context

Jan. 10, 2007

DOR receives payment from Sigma-Tau for rights to negotiate orBec alliance

Jan. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...